Szabolcs Kiss, Dávid Németh, Péter Hegyi , Mária Földi , Zsolt Szakács, Bálint Erőss , Benedek Tinusz , Péter Jenő Hegyi, Patrícia Sarlós , Hussain Alizadeh, BMJ Open 2021 May 19;11(5):e042374.
Scientific corner
Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta analysis
https://pubmed.ncbi.nlm.nih.gov/34011580/
https://bmjopen.bmj.com/content/bmjopen/11/5/e042374.full.pdf
The results support the hypothesis that patients with active UC have a better chance of clinical remission if GMA is administered as an adjunctive therapy. As regards the frequency of AEs, we found no statistically significant difference between the two groups. With regard to remission maintenance, GMA was identified as an effective alternative therapeutic option
Clinical remission / combination / efficacy / gastroenterology / gma / haematology / immunology / meta-analysis / Safety / ulcerative colitis /
Contact UsFor more information
Contact Us